| |
| |
|
| Insider
Information: |
Colangelo Dominick |
| Relationship: |
|
| City: |
Waltham |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
267,221 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$9,609,335 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
267,221 |
|
|
| Total
Value |
$9,609,335 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Oscient Pharmaceuticals Corp |
OSCIQ |
EVP Corporate Dev & Op... |
2008-02-25 |
46,469 |
2005-06-30 |
0 |
Premium* |
|
|
Vericel Corp |
VCEL |
|
2024-05-16 |
220,752 |
2014-09-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
84 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OSCIQ |
Oscient Pharmaceuticals C... |
EVP Corporate Dev & Operations |
• – – |
2006-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
80,000 |
80,000 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
EVP Corporate Dev & Operations |
• – – |
2006-02-27 |
4/A |
A |
$0.00 |
$0 |
D/D |
80,000 |
81,874 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
EVP Corporate Dev & Operations |
• – – |
2007-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
19,562 |
29,797 |
0 |
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
EVP Corporate Dev & Operations |
• – – |
2008-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
14,672 |
46,469 |
0 |
- |
|
| VCEL |
Vericel Corp |
President and CEO |
• • – |
2020-02-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,937 |
175,970 |
0 |
- |
|
| VCEL |
Vericel Corp |
President and CEO |
• • – |
2021-02-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,938 |
218,040 |
0 |
- |
|
| VCEL |
Vericel Corp |
President and CEO |
• • – |
2021-02-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
222,462 |
0 |
- |
|
| VCEL |
Vericel Corp |
President and CEO |
• • – |
2022-02-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,937 |
150,170 |
0 |
- |
|
| VCEL |
Vericel Corp |
President and CEO |
• • – |
2022-02-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
154,621 |
0 |
- |
|
| VCEL |
Vericel Corp |
President and CEO |
• • – |
2022-02-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,937 |
160,307 |
0 |
- |
|
| VCEL |
Vericel Corp |
President and CEO |
• • – |
2023-02-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,938 |
164,004 |
0 |
- |
|
| VCEL |
Vericel Corp |
President and CEO |
• • – |
2023-02-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
168,251 |
0 |
- |
|
| VCEL |
Vericel Corp |
President and CEO |
• • – |
2023-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,700 |
176,436 |
0 |
- |
|
| VCEL |
Vericel Corp |
President and CEO |
• • – |
2023-02-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,938 |
179,951 |
0 |
- |
|
| VCEL |
Vericel Corp |
President and CEO |
• • – |
2023-12-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
6,757 |
169,985 |
0 |
- |
|
| VCEL |
Vericel Corp |
President and CEO |
• • – |
2024-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
177,485 |
0 |
- |
|
| VCEL |
Vericel Corp |
President and CEO |
• • – |
2024-02-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
38,887 |
199,013 |
0 |
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
EVP Corporate Dev & Operations |
• – – |
2008-02-08 |
4 |
B |
$1.24 |
$2,479 |
D/D |
2,000 |
31,797 |
2.66 |
- |
|
| VCEL |
Vericel Corp |
President and CEO |
• • – |
2018-05-17 |
4 |
OE |
$1.95 |
$66,908 |
D/D |
29,360 |
82,445 |
0 |
- |
|
| VCEL |
Vericel Corp |
President and CEO |
• • – |
2018-10-04 |
4 |
OE |
$1.95 |
$146,250 |
D/D |
75,000 |
150,163 |
0 |
- |
|
| VCEL |
Vericel Corp |
President and CEO |
• • – |
2019-02-15 |
4 |
OE |
$1.95 |
$99,999 |
D/D |
36,192 |
111,355 |
0 |
- |
|
| VCEL |
Vericel Corp |
President and CEO |
• • – |
2020-02-13 |
4 |
OE |
$1.95 |
$56,204 |
D/D |
23,438 |
196,229 |
0 |
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
SVP Corporate Dev & Operations |
• – – |
2005-06-30 |
4 |
A |
$2.25 |
$4,217 |
D/D |
1,874 |
1,874 |
|
- |
|
| VCEL |
Vericel Corp |
President and CEO |
• • – |
2014-09-16 |
4 |
B |
$2.55 |
$51,000 |
D/D |
20,000 |
20,000 |
2.81 |
- |
|
| VCEL |
Vericel Corp |
President and CEO |
• • – |
2019-10-01 |
4 |
OE |
$2.65 |
$106,000 |
D/D |
40,000 |
152,783 |
0 |
- |
|
84 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
